Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-19-019531

President sold 50,000 shares at $50.00 ($2,500,065)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Novak Rodger President 2019-07-10 Sale −50,000 $50.00 $2,500,065 848,007 D
Open-market sales · 50,000 sh · avg $50.00 · $2,500,065
Loading xslF345X03/doc4.xml…